Clinicians and mental health professionals, join the New Jersey Counseling Association (NJCA) and Relief Mental Health on Friday, October 11, 2024, for an in-depth exploration of innovative treatments for psychiatric diagnoses, including transcranial magnetic stimulation (TMS) and SPRAVATO® (esketamine). This engaging webinar, presented by Relief’s Director of Clinical Strategy Don Mitckess, LCPC, CRADC, will delve into the ethical considerations surrounding these treatments and how they benefit individuals dealing with depression, anxiety, OCD, and more.
Clinicians will earn 1 Ethics CE NBCC Credit Hour. Don’t miss this opportunity to expand your knowledge and enhance your practice with insights into these cutting-edge treatments. Share this with your network and join us for a meaningful discussion on ethical practices in modern mental health care!
